FiercePharmaAsia—Nanjing Legend, Eisai-Biogen, Impax and more by Angus Liu Friday, January 5, 2018 Legend teams with J&J on CAR-T project, Eisai and Biogen's Alzheimer's drug fails in early readout, Impax and Bora Pharma ink deal.
